Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA's drug shortage list, meaning compounders can no longer prepare and dispense the drug.

The co-founder of biotech firm Regeneron Pharmaceuticals (NASDAQ:REGN) said in a newspaper interview that popular weight-loss ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Tom Yeung here with the Sunday Digest. In mid-2019, the U.S. Federal Reserve began cutting interest rates for the first time ...

Ruwaida Amer was on the upper floor of her home at night when the sound of a rocket pierced the air and then broken glass started falling ...

Democrat Tim Walz used his debut campaign appearance on a Sunday news show to try to fend off criticism of his stand on abortion rights.